Patents by Inventor Sarah Serl

Sarah Serl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid viral formulations
    Patent number: 9610309
    Abstract: Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients and a liquid carrier. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: April 4, 2017
    Assignee: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • Lyophilized viral formulations
    Patent number: 9610352
    Abstract: Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: April 4, 2017
    Assignee: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • LIQUID VIRAL FORMULATIONS
    Publication number: 20150224155
    Abstract: Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients and a liquid carrier. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Application
    Filed: April 23, 2015
    Publication date: August 13, 2015
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • LYOPHILIZED VIRAL FORMULATIONS
    Publication number: 20150224198
    Abstract: Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Application
    Filed: April 22, 2015
    Publication date: August 13, 2015
    Applicant: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • Lyophilized viral formulations
    Patent number: 9044498
    Abstract: Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: June 2, 2015
    Assignee: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • Liquid viral formulations
    Patent number: 9045728
    Abstract: Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients and a liquid carrier. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: June 2, 2015
    Assignee: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • METHODS OF PURIFYING VIRUSES USING GEL PERMEATION CHROMATOGRAPHY
    Publication number: 20120273424
    Abstract: Provided herein are elution buffers and methods for purifying viruses using gel permeation chromatography. The methods are useful, for example, in increasing recovery of a virus from a gel permeation chromatography column. The buffers for use in the methods include at least one excipient selected from histidine or sucrose, a divalent cation, a non-ionic detergent, and a phosphate buffered saline.
    Type: Application
    Filed: April 27, 2012
    Publication date: November 1, 2012
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Allison Hagerman, Sarah Serl, Roxna Kapadia
  • LYOPHILIZED VIRAL FORMULATIONS
    Publication number: 20120141528
    Abstract: Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv
  • LIQUID VIRAL FORMULATIONS
    Publication number: 20120141421
    Abstract: Provided herein are liquid viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The liquid viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients and a liquid carrier. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Sarah Serl, Leo Pavliv